These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 26261345

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Polymorphisms in Pfcrt and Pfmdr-1 genes after five years withdrawal of chloroquine for the treatment of Plasmodium falciparum malaria in West Bengal, India.
    Chatterjee M, Ganguly S, Saha P, Guha SK, Basu N, Bera DK, Maji AK.
    Infect Genet Evol; 2016 Oct; 44():281-285. PubMed ID: 27448953
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Correlation of molecular markers, Pfmdr1-N86Y and Pfcrt-K76T, with in vitro chloroquine resistant Plasmodium falciparum, isolated in the malaria endemic states of Assam and Arunachal Pradesh, Northeast India.
    Shrivastava SK, Gupta RK, Mahanta J, Dubey ML.
    PLoS One; 2014 Oct; 9(8):e103848. PubMed ID: 25105963
    [Abstract] [Full Text] [Related]

  • 28. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America.
    Mehlotra RK, Fujioka H, Roepe PD, Janneh O, Ursos LM, Jacobs-Lorena V, McNamara DT, Bockarie MJ, Kazura JW, Kyle DE, Fidock DA, Zimmerman PA.
    Proc Natl Acad Sci U S A; 2001 Oct 23; 98(22):12689-94. PubMed ID: 11675500
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.
    Mohammed A, Ndaro A, Kalinga A, Manjurano A, Mosha JF, Mosha DF, van Zwetselaar M, Koenderink JB, Mosha FW, Alifrangis M, Reyburn H, Roper C, Kavishe RA.
    Malar J; 2013 Nov 14; 12():415. PubMed ID: 24225406
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: an urgent need to re-examine malaria drug policy.
    Al-Mekhlafi AM, Mahdy MA, Al-Mekhlafi HM, Azazy AA, Fong MY.
    Parasit Vectors; 2011 May 27; 4():94. PubMed ID: 21619624
    [Abstract] [Full Text] [Related]

  • 35. Functional characterization of the Plasmodium falciparum chloroquine-resistance transporter (PfCRT) in transformed Dictyostelium discoideum vesicles.
    Papakrivos J, Sá JM, Wellems TE.
    PLoS One; 2012 May 27; 7(6):e39569. PubMed ID: 22724026
    [Abstract] [Full Text] [Related]

  • 36. Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistance.
    Small-Saunders JL, Hagenah LM, Wicht KJ, Dhingra SK, Deni I, Kim J, Vendome J, Gil-Iturbe E, Roepe PD, Mehta M, Mancia F, Quick M, Eppstein MJ, Fidock DA.
    PLoS Pathog; 2022 Feb 27; 18(2):e1010278. PubMed ID: 35130315
    [Abstract] [Full Text] [Related]

  • 37. PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX.
    Bray PG, Mungthin M, Hastings IM, Biagini GA, Saidu DK, Lakshmanan V, Johnson DJ, Hughes RH, Stocks PA, O'Neill PM, Fidock DA, Warhurst DC, Ward SA.
    Mol Microbiol; 2006 Oct 27; 62(1):238-51. PubMed ID: 16956382
    [Abstract] [Full Text] [Related]

  • 38. pfcrt Polymorphism and the spread of chloroquine resistance in Plasmodium falciparum populations across the Amazon Basin.
    Vieira PP, Ferreira MU, Alecrim Md, Alecrim WD, da Silva LH, Sihuincha MM, Joy DA, Mu J, Su XZ, Zalis MG.
    J Infect Dis; 2004 Jul 15; 190(2):417-24. PubMed ID: 15216481
    [Abstract] [Full Text] [Related]

  • 39. Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH.
    Bennett TN, Kosar AD, Ursos LM, Dzekunov S, Singh Sidhu AB, Fidock DA, Roepe PD.
    Mol Biochem Parasitol; 2004 Jan 15; 133(1):99-114. PubMed ID: 14668017
    [Abstract] [Full Text] [Related]

  • 40. Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.
    Legrand E, Yrinesi J, Ekala MT, Péneau J, Volney B, Berger F, Bouchier C, Bertani S, Musset L, Meynard JB, Mercereau-Puijalon O.
    Antimicrob Agents Chemother; 2012 Mar 15; 56(3):1382-9. PubMed ID: 22232280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.